Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.

Rodriguez EF, Scheithauer BW, Giannini C, Rynearson A, Cen L, Hoesley B, Gilmer-Flynn H, Sarkaria JN, Jenkins S, Long J, Rodriguez FJ.

Acta Neuropathol. 2011 Mar;121(3):407-20. doi: 10.1007/s00401-010-0784-9. Epub 2010 Nov 28.

2.

The role of GABA(A) receptor subtypes as analgesic targets.

Mirza NR, Munro G.

Drug News Perspect. 2010 Jul-Aug;23(6):351-60. doi: 10.1358/dnp.2010.23.6.1489909. Review.

PMID:
20697602
3.

Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.

Kim KY, Ju WK, Hegedus B, Gutmann DH, Ellisman MH.

Neuroscience. 2010 Sep 29;170(1):178-88. doi: 10.1016/j.neuroscience.2010.06.017. Epub 2010 Jun 23.

4.

Neurogranin enhances synaptic strength through its interaction with calmodulin.

Zhong L, Cherry T, Bies CE, Florence MA, Gerges NZ.

EMBO J. 2009 Oct 7;28(19):3027-39. doi: 10.1038/emboj.2009.236. Epub 2009 Aug 27.

5.

Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors.

Boer K, Troost D, Timmermans W, van Rijen PC, Spliet WG, Aronica E.

Brain Pathol. 2010 Jan;20(1):234-44. doi: 10.1111/j.1750-3639.2009.00268.x. Epub 2009 Apr 7.

PMID:
19371356
6.

Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.

Rodriguez FJ, Giannini C, Asmann YW, Sharma MK, Perry A, Tibbetts KM, Jenkins RB, Scheithauer BW, Anant S, Jenkins S, Eberhart CG, Sarkaria JN, Gutmann DH.

J Neuropathol Exp Neurol. 2008 Dec;67(12):1194-204. doi: 10.1097/NEN.0b013e31818fbe1e.

7.
8.

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

Jones DT, Kocialkowski S, Liu L, Pearson DM, B├Ącklund LM, Ichimura K, Collins VP.

Cancer Res. 2008 Nov 1;68(21):8673-7. doi: 10.1158/0008-5472.CAN-08-2097.

9.

Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients.

Rodriguez FJ, Perry A, Gutmann DH, O'Neill BP, Leonard J, Bryant S, Giannini C.

J Neuropathol Exp Neurol. 2008 Mar;67(3):240-9. doi: 10.1097/NEN.0b013e318165eb75.

10.

The role of GABA in the mediation and perception of pain.

Enna SJ, McCarson KE.

Adv Pharmacol. 2006;54:1-27. Review.

PMID:
17175808
11.

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.

Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR.

Ann Neurol. 2006 Mar;59(3):490-8.

PMID:
16453317
12.
13.

Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.

Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ.

J Neuropathol Exp Neurol. 2004 Dec;63(12):1236-42.

PMID:
15624760
14.

Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study.

Fedi M, Anne Mitchell L, Kalnins RM, Gutmann DH, Perry A, Newton M, Brodtmann A, Berkovic SF.

J Clin Neurosci. 2004 Sep;11(7):745-7.

PMID:
15337138
15.

An electron microscopic study of normal optic nerve and of an optic-nerve glioma.

LUSE SA.

J Neurosurg. 1961 Jul;18:466-78. No abstract available.

PMID:
13764421
16.

Immunophenotype of pleomorphic xanthoastrocytoma.

Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR.

Am J Surg Pathol. 2002 Apr;26(4):479-85.

PMID:
11914626
17.

Control of translation by the target of rapamycin proteins.

Gingras AC, Raught B, Sonenberg N.

Prog Mol Subcell Biol. 2001;27:143-74. Review. No abstract available.

PMID:
11575159
18.

Role of synaptotagmin, a Ca2+ and inositol polyphosphate binding protein, in neurotransmitter release and neurite outgrowth.

Mikoshiba K, Fukuda M, Ibata K, Kabayama H, Mizutani A.

Chem Phys Lipids. 1999 Apr;98(1-2):59-67. Review.

PMID:
10358928
19.

Ultrastructural pathology of glial brain tumors revisited: a review.

Liberski PP, Kordek R.

Ultrastruct Pathol. 1997 Jan-Feb;21(1):1-31. Review.

PMID:
9029763
20.

Immunohistochemical characterization of subependymal giant cell astrocytomas.

Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR.

Acta Neuropathol. 1996;91(4):368-75.

PMID:
8928613

Supplemental Content

Support Center